Wealth Quarterback’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$46K Sell
554
-99
-15% -$8.91K 0.03% 250
2021
Q2
$60K Buy
+653
New +$58.1K 0.04% 214
2020
Q2
Sell
-1,407
Closed -$116K 544
2020
Q1
$116K Buy
1,407
+371
+36% +$33.1K 0.11% 142
2019
Q4
$98.2K Buy
+1,036
New +$93K 0.09% 163

Other funds holding NVS

Wealth Quarterback's NVS Position: Q3 2021 in Review

Wealth Quarterback reduced its Novartis (NVS) stake by 15% in Q3 2021, selling an estimated $8.91K and leaving 554 shares worth $46K. The position accounts for 0.03% of the portfolio, ranked #250.

Wealth Quarterback first reported a position in NVS in Q4 2019 and has held it in 4 quarters since. The position peaked at $116K in Q1 2020. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • Wealth Quarterback held 554 shares of Novartis worth $46K as of Q3 2021.
  • Wealth Quarterback sold 99 Novartis shares in Q3 2021, an estimated $8.91K.
  • Novartis made up 0.03% of Wealth Quarterback's portfolio in Q3 2021, its #250 holding.
  • Wealth Quarterback first reported a position in Novartis in Q4 2019 and has held it in 4 quarters since.
  • Wealth Quarterback's Novartis position peaked at $116K in Q1 2020.
  • 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.